Aortic stenosis natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
'''Associate Editors-In-Chief:''' Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu]; [[User:Abdarabi|Abdul-Rahman Arabi, M.D.]] [mailto:abdarabi@yahoo.com]; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu] | '''Associate Editors-In-Chief:''' Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu]; [[User:Abdarabi|Abdul-Rahman Arabi, M.D.]] [mailto:abdarabi@yahoo.com]; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu] | ||
==Overview== | |||
As with any surgical intervention, surgical therapies for aortic stenosis carry risks and potential for complication. These complications commonly include vascular issues such as vascular complications and mitral valve injury. | |||
==Complications== | ==Complications== | ||
Complications stemming from aortic stenosis surgical therapies primarily involve vascular complications. | |||
The most common methodology is a perclose or angioseal closure and is the most preferable for this tenuous patient population. This particular closure method calls for a mandatory attention to the meticulous access technique. An antegrade approach may be a viable method in some patient populations. An example of such would be the venuous access with transseptal approach. This particular procedure can be done in a select population of patients. Many patients are unable to tolerate this approach as the hemodynamic effects of mitral valve incompetence is a stiff wire as it is placed across the mitral valve. Mitral valve injury can occur as a result of such rigidity. | |||
==Prognosis== | ==Prognosis== | ||
30% reduction in gradient is expected as the immediate result Patient survival after repeat BAV is higher than that of untreated patients. | 30% reduction in gradient is expected as the immediate result of surgical intervention. Patient survival after repeat BAV is higher than that of untreated patients. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:DiseaseState]] | [[Category:DiseaseState]] | ||
[[Category:Signs and symptoms]] | [[Category:Signs and symptoms]] | ||
| Line 24: | Line 24: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Mature chapter]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 19:36, 25 July 2011
|
Aortic Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty |
|
Transcatheter Aortic Valve Replacement (TAVR) |
|
Case Studies |
|
Aortic stenosis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Aortic stenosis natural history, complications and prognosis |
|
FDA on Aortic stenosis natural history, complications and prognosis |
|
CDC on Aortic stenosis natural history, complications and prognosis |
|
Aortic stenosis natural history, complications and prognosis in the news |
|
Blogs on Aortic stenosis natural history, complications and prognosis |
|
Directions to Hospitals Treating Aortic stenosis natural history, complications and prognosis |
|
Risk calculators and risk factors for Aortic stenosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editors-In-Chief: Claudia P. Hochberg, M.D. [2]; Abdul-Rahman Arabi, M.D. [3]; Keri Shafer, M.D. [4]
Overview
As with any surgical intervention, surgical therapies for aortic stenosis carry risks and potential for complication. These complications commonly include vascular issues such as vascular complications and mitral valve injury.
Complications
Complications stemming from aortic stenosis surgical therapies primarily involve vascular complications.
The most common methodology is a perclose or angioseal closure and is the most preferable for this tenuous patient population. This particular closure method calls for a mandatory attention to the meticulous access technique. An antegrade approach may be a viable method in some patient populations. An example of such would be the venuous access with transseptal approach. This particular procedure can be done in a select population of patients. Many patients are unable to tolerate this approach as the hemodynamic effects of mitral valve incompetence is a stiff wire as it is placed across the mitral valve. Mitral valve injury can occur as a result of such rigidity.
Prognosis
30% reduction in gradient is expected as the immediate result of surgical intervention. Patient survival after repeat BAV is higher than that of untreated patients.